Healthcare Industry News: absorbable hemostat
News Release - December 4, 2006
Medafor's FlexiTip(TM) Applicator Facilitates Wound Access During Surgery
Delivers Arista(TM) AH Absorbable Surgical Hemostat to Difficult to Reach Bleeding WoundsMINNEAPOLIS, Dec. 4 (HSMN NewsFeed) -- Medafor, Inc., announced today the introduction of the FlexiTip(TM) applicator for use with its Arista(TM) AH absorbable hemostat. Arista AH is the simple, safe and effective hemostatic powder recently approved by the FDA for most types of surgery including cardiac, orthopedic, spinal and general surgical applications.
The FlexiTip applicator is a lightweight, plastic device with a long, flexible tube to provide accurate delivery of Arista AH powder deep into hemorrhagic wounds and into difficult to reach locations during surgery. The Arista AH bellows applicator attaches to the end of the FlexiTip to create a reservoir of powder which flows through the tube when the bellows are compressed.
Arista AH consists of Medafor's patented Microporous Polysaccharide Hemospheres (MPH®), a plant-based, flowable powder engineered to rapidly dehydrate blood, enhancing clotting on contact. Arista AH facilitates the formation of a highly resilient, natural clot within just a few minutes regardless of the patient's coagulation status.
Arista AH is the only new generation surgical hemostat that is instantly ready to use, requiring no mixing, no addition of patient blood or other components and no special handling or storage conditions. Pre-clinical evaluations, clinical studies and surgical use have shown the hemostatic capabilities of Arista AH to be comparable to the current popular choice of surgical hemostatic materials, while its unique formulation allows for rapid and complete absorption within 24 to 48 hours. Because Arista AH degrades so rapidly, it does not promote infection.
"As with the recent introduction of Arista AH to the U.S. surgical market, the arrival of the FlexiTip applicator significantly improves the options available for safe, efficacious hemostasis during surgical procedures," said Gary Shope, Medafor C.E.O.
For information about Medafor's technology, research and products, visit http://www.medafor.com .
Medafor, Inc., is a privately held Minnesota Corporation based in Minneapolis.
This release may contain forward-looking statements based on current expectations of future events. If underlying assumptions prove inaccurate, or unforeseen risks or circumstances materialize, actual results could vary materially from expectations and projections stated herein. The Company assumes no obligation to update any forward-looking statements as a result of new information or future developments.
MPH®, FlexiTip(TM) and Arista(TM) AH are trademarks of Medafor, Inc.
Source: Medafor
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
